Endonovo Therape Stock Price, News & Analysis
Company Description
Endonovo Therape (OTC Link: ENDV) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $144.6K.
On a trailing twelve-month basis, Endonovo Therape reported revenue of $135K with net income of -$18.5M. The company operates at a net profit margin of -13649.2%.
This page provides a comprehensive overview of ENDV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Endonovo Therape (ENDV) stock last traded at $0.0001. At a market capitalization of $144.6K, ENDV is classified as a micro-cap stock with approximately 1.8B shares outstanding.
Latest News
Endonovo Therape has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include fda approval, clinical trial, partnership. View all ENDV news →
SEC Filings
Financial Highlights
Endonovo Therape generated $135K in revenue over the trailing twelve months, retaining a 92.6% gross margin, operating income reached -$3.3M (-2411.7% operating margin), and net income was -$18.5M, reflecting a -13649.2% net profit margin. The company generated -$679K in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Endonovo Therape (ENDV) currently stands at 519.0 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 16.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Endonovo Therape (ENDV) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
ENDV Company Profile & Sector Positioning
Endonovo Therape (ENDV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ENDV often look at related companies in the same sector, including Globestar Therapeutics Corp (GSTC), Tracon Pharmaceu (TCON), Trevena Inc (TRVN), Scorpius Holdings (SCPX), and Vincerx Pharma Inc (VINC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENDV's relative position within its industry.